Steven Katz

Company: TriSalus Life Sciences

Job title: Chief Medical Officer

Seminars:

TME Modelling & Dose Optimization for Solid Tumor Immunotherapy Development – the TriSalus Translational & Clinical Experience 1:45 pm

Addressing organ-specific immunosuppressive barriers through strategic MoA selection Reflect on the integration of appropriate delivery strategies to enable therapeutic performance Analyze the selection of immunologic read-outs for early phase clinical trials to enable detection of biologic activityRead more

day: Conference Day 1

Workshop B: Advancing Translational Models for Improving Predictive Validity Within Innate Immune System-Targeted Therapies 7:00 am

This workshop aims to bridge the translational gap in the development of therapies targeting the innate immune system, with a specific focus on STING & TLR receptors. Attendees will gain insights into selecting, utilizing and validating translational models for effective translation of preclinical findings into clinical success. Overview of suitable preclinical models for evaluating STING…Read more

day: Conference Day 2